![Biao He](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Biao He
Director/Miembro de la Junta en BioEclipse Therapeutics, Inc. .
Cargos activos de Biao He
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BioEclipse Therapeutics, Inc.
![]() BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Biao He
Antiguos cargos conocidos de Biao He.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Tsinghua Silicon Valley Capital
![]() Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Inversor de Capital Privado | - | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectorial
Finance | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Tsinghua Silicon Valley Capital
![]() Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Finance |
BioEclipse Therapeutics, Inc.
![]() BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Biao He
- Experiencia